Advertisement
Screener

THE PENNANT GROUP, INC. (PNTG) EBITDA

THE PENNANT GROUP, INC. (PNTG) EBITDA

  • 2026-06-30: Basis Reported; EBITDA $20.30M*; Operating income $17.19M; Depreciation and amortization $3.11M*.
  • 2026-03-31: Basis Reported; EBITDA $19.92M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA $19.83M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA $12.30M*; Operating income $10.24M; Depreciation and amortization $2.06M*.

Complete source-backed ebitda history.

Available history
2017-12-31 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported$20.30M*$17.19M$3.11M*$297.98M6.81%*$6.34M*$21.83M*(m)(m)$21.61M$3.94M
2026-03-31Reported$19.92M(m)(m)(m)6.98%$5.27M-$3.40M(m)(m)$19.69M$3.79M
2025-12-31Reported$19.83M(m)(m)(m)6.85%(m)(m)(m)(m)(m)(m)
2025-09-30Reported$12.30M*$10.24M$2.06M*$229.04M5.37%*$3.46M*$13.92M*(m)(m)$19.30M$2.52M
2025-06-30Reported$13.75M*$11.53M$2.22M*$219.50M6.27%*$3.06M*$34.64M*(m)(m)$17.60M$2.60M
2025-03-31Reported$14.54M(m)(m)(m)6.93%$1.96M-$21.23M(m)(m)$14.84M$2.85M
2024-12-31Reported$11.06M(m)(m)(m)5.86%(m)(m)(m)(m)(m)(m)
2024-09-30Reported$12.29M*$10.79M$1.49M*$180.69M6.80%*$908.00K*$7.69M*(m)(m)$13.02M$1.35M
2024-06-30Reported$11.03M*$9.56M$1.47M*$168.75M6.54%*$1.62M*$10.49M*(m)(m)$11.88M$1.84M
2024-03-31Reported$9.86M(m)(m)(m)6.28%$3.14M$545.00K(m)(m)$11.44M$1.76M
2023-12-31Reported$8.88M(m)(m)(m)6.08%(m)(m)(m)(m)(m)(m)
2023-09-30Reported$8.38M*$7.06M$1.32M*$140.19M5.98%*$1.77M*$12.38M*(m)(m)$9.42M$1.07M
2023-06-30Reported$7.47M*$6.26M$1.21M*$132.28M5.65%*$1.66M*$6.54M*(m)(m)$8.79M$1.92M
2023-03-31Reported$5.56M(m)(m)(m)4.40%$2.31M$9.00M(m)(m)$8.71M$907.00K
2022-12-31Reported$7.61M(m)(m)(m)6.10%(m)(m)(m)(m)(m)(m)
2022-09-30Reported$8.39M*$7.14M$1.25M*$118.35M7.09%*$2.56M*$8.07M*(m)(m)$5.88M$1.07M
2022-06-30Reported-$1.84M*-$3.12M$1.28M*$116.32M-1.58%*$5.47M*$8.97M*(m)(m)$9.74M-$1.38M
2022-03-31Reported$3.47M(m)(m)(m)3.05%$2.39M-$4.07M(m)(m)(m)$542.00K
2021-12-31Reported-$950,000.00(m)(m)(m)-0.85%(m)(m)(m)(m)(m)(m)
2021-09-30Reported$2.90M*$1.70M$1.20M*$111.92M2.59%*$1.73M*-$1.26M*(m)(m)(m)$69.00K
2021-06-30Reported$4.74M*$3.57M$1.17M*$110.34M4.29%*$1.66M*-$4.54M*(m)(m)(m)$604.00K
2021-03-31Reported$2.79M(m)(m)(m)2.64%$754.00K-$7.27M(m)(m)(m)$340.00K
2020-12-31Reported$5.33M(m)(m)(m)4.94%(m)(m)(m)(m)(m)(m)
2020-09-30Reported$5.69M*$4.48M$1.21M*$98.40M5.78%*$1.73M*$9.69M*(m)(m)(m)$104.00K
2020-06-30Reported$7.28M*$6.08M$1.20M*$92.74M7.85%*$3.05M*$41.31M*(m)(m)(m)$1.44M
2020-03-31Reported$5.29M(m)(m)(m)5.76%$2.92M$2.09M(m)(m)(m)$889.00K
2019-12-31Reported-$428,000.00(m)(m)(m)-0.48%(m)(m)(m)(m)(m)(m)
2019-09-30Reported$3.00M*$1.93M$1.07M*$88.40M3.39%*$994.00K*$8.19M*(m)(m)(m)$123.00K
2019-06-30Reported$4.27M*$3.31M$962.00K*$82.73M5.17%*$2.74M*$5.42M*(m)(m)(m)-$375.00K
2019-03-31Reported$2.64M(m)(m)(m)3.38%$901.00K-$1.41M(m)(m)(m)$343.00K
2018-12-31Reported$5.5M(m)(m)(m)7.30%(m)(m)(m)(m)(m)(m)
2018-09-30Reported(m)$5.80M(m)$72.95M(m)(m)(m)(m)(m)(m)$1.39M

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported$60.42M(m)(m)(m)6.38%$12.04M$48.29M(m)(m)$71.08M$11.87M
2024-12-31Reported$44.24M(m)(m)(m)6.36%$8.99M$39.30M(m)(m)$50.21M$7.03M
2023-12-31Reported$30.3M(m)(m)(m)5.56%$8.11M$33.09M(m)(m)$36.67M$5.67M
2022-12-31Reported$17.64M(m)(m)(m)3.73%$14.17M$9.04M(m)(m)$33.98M$1.65M
2021-12-31Reported$9.48M(m)(m)(m)2.16%$6.30M-$18.22M(m)(m)$36.26M$582.00K
2020-12-31Reported$23.59M(m)(m)(m)6.03%$7.25M$50.20M(m)(m)(m)$2.35M
2019-12-31Reported$9.48M(m)(m)(m)2.80%$6.71M$9.55M(m)(m)(m)$2.08M
2018-12-31Reported$23.6M(m)(m)(m)8.25%$3.60M$23.27M(m)(m)(m)$4.35M
2017-12-31Reported$17.95M(m)(m)(m)7.15%$3.13M$17.25M(m)(m)(m)$5.38M

Similar stocks

Stock NameCountryMarket CapPE Ratio
U S PHYSICAL THERAPY INC /NV (USPH)United States$1.251B32.48
Omada Health, Inc. (OMDA)United States$1.207B309.08
InnovAge Holding Corp. (INNV)United States$1.206B-635.60
Strata Critical Medical, Inc. (SRTA)United States$0.467B11.33
Privia Health Group, Inc. (PRVA)United States$2.477B115.52
GeneDx Holdings Corp. (WGS)United States$2.638B-19.23
DocGo Inc. (DCGO)United States$0.034B-0.25
VSEE HEALTH, INC. (VSEE)United States$0.003B
Agape ATP Corp (ATPC)$0.002B
LifeStance Health Group, Inc. (LFST)United States$4.510B80.86